BUPROPION HCl ER (XL)
NDC 70756-830, BUPROPION HCl ER, tablet, extended release, from Lifestar Pharma LLC.
- Product NDC
- 70756-830
- Status
- Listed
- Labeler
- Lifestar Pharma LLC
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA022497
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70756-830 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BUPROPION HYDROCHLORIDE450 mg/1
Pharmacologic classes
Aminoketone [EPC]; Dopamine Uptake Inhibitors [MoA]; Increased Dopamine Activity [PE]; Increased Norepinephrine Activity [PE]; Norepinephrine Uptake Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70756-830-16 | 70756083016 | 16000 TABLET, EXTENDED RELEASE in 1 BOX (70756-830-16) |
| 70756-830-30 | 70756083030 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (70756-830-30) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/df959e1b-3f6d-42cf-8521-fe03b5a4ceb8NADAC price for package 70756083030
GET /v1/drugs/nadac/70756083030
Use it
Look up 70756-830 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70756-830 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70756-830. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.